Skip to NavigationSkip to content

Pharmafile - Research and Development News

4.3 million people in the EU are affected by rare cancers, and an estimated 500,000 new cases are diagnosed annually; Dr Terese Johansson highlights...
European approval for Novartis' biosimilar version of a Roche blockbuster and a 100-year old Alzheimer's theory is confirmed. Check out the week's...
New research has identified direct evidence that the body’s immune system attacks the brain in Parkinson’s disease, seemingly confirming a theory...
A new study funded by Cancer Research UK and carried out by the University of Cambridge has identified the ages when women are most at risk from...
Hasini Jayatilaka and a team of researchers say they have uncovered the biochemical mechanism which drives cancer cells to break away from a...
Novartis has posted positive news from the Cantos clinical trial study that saw its drug, Canakinumab, pull of a surprise result to reduce the risk...
More drama in the Indian pharma sector as the FDA announces it has enforced a ban on the import of drug products manufactured at three sites owned...
Shire has revealed that the FDA has approved its long-acting and interestingly named ADHD drug, Mydayis. The approval comes more than 10 years from...
Researchers from the University of Adelaide have linked a specific type of irritable bowel syndrome with the exhaustion of the immune system. In...
The Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) of the FDA recommends that data from a recent study into Novo Nordisk's Victoza’s...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches